• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Artara Therapeutics Inc (NQ: TARA )

    1.850 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Oct 17, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 21
    Open 1.850
    Bid (Size) 1.770 (4)
    Ask (Size) 2.070 (4)
    Prev. Close 1.850
    Today's Range 1.850 - 1.850
    52wk Range 1.040 - 5.240
    Shares Outstanding 11,235,731
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    TARA Stock Earnings: Protara Therapeutics Beats EPS for Q2 2024
    TARA stock results show that Protara Therapeutics beat analyst estimates for earnings per share the second quarter of 2024. 
    Via InvestorPlace
    TARA Stock Earnings: Protara Therapeutics Misses EPS for Q1 2024
    TARA stock results show that Protara Therapeutics missed analyst estimates for earnings per share the first quarter of 2024. 
    Via InvestorPlace

    Performance

    YTD
    -11.90%
    -11.90%
    1 Month
    +1.65%
    +1.65%
    3 Month
    -18.14%
    -18.14%
    6 Month
    -32.73%
    -32.73%
    1 Year
    +17.83%
    +17.83%

    More News

    Read More
    Alphabet To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Monday
    Via Benzinga
    Protara Therapeutics Shares Interim Data From Bladder Cancer Study, Raises $45M Via Equity
    Via Benzinga
    Exposures Product Safety
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    Recap: Protara Therapeutics Q1 Earnings
    Via Benzinga
    Protara Therapeutics Releases Early Cut Data From Investigational Cell-Based Therapy For Bladder Cancer
    Via Benzinga
    Protara Therapeutics Shares Retrospective Analysis Of OK-432 In Rare Lymphatic Malformations
    Via Benzinga
    3 Stocks That Could Help You Retire on a Private Island
    Via InvestorPlace
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    Protara Therapeutics: Q3 Earnings Insights
    Via Benzinga
    Stocks That Hit 52-Week Lows On Wednesday
    Via Benzinga
    Stocks That Hit 52-Week Lows On Monday
    Via Benzinga
    Insider Buying 2022: 15 Stocks to Bet On Despite the Bear Market
    Via InvestorPlace
    Stocks That Hit 52-Week Lows On Friday
    Via Benzinga
    Executives Buy Around $35M Of 4 Penny Stocks: Nextdoor, GreenLight Biosciences And More
    Via Benzinga
    Stocks That Hit 52-Week Lows On Tuesday
    Via Benzinga
    Stocks That Hit 52-Week Lows On Monday
    Via Benzinga
    Recap: Protara Therapeutics Q4 Earnings
    Via Benzinga
    Stocks That Hit 52-Week Lows On Friday
    Via Benzinga
    Stocks That Hit 52-Week Lows On Wednesday
    Via Benzinga
    Stocks That Hit 52-Week Lows On Wednesday
    Via Benzinga
    Stocks That Hit 52-Week Lows On Friday
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.